CrossrefInfokaart
Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion
Brain · 2026-11-04 · 149 (11) · 3681-3682
DOI: 10.1093/brain/awag308 ↗Abstrakt
This scientific commentary refers to ‘Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis’, by Georgieva et al. (https://doi.org/10.1093/brain/awag171).
EUVIMED